MDS - AML - 2020 Spring Virtual Conference: When MDS becomes AML - for High-Risk MDS Patients

Dr. Daniel Pollyea, MD, MS from the University of Colorado Health explained the definition of High-Risk MDS, or Myelodysplastic Syndromes, as well as how it can change into AML, or Acute Myeloid Leukemia. He answered questions from the live audience in this recording.